Texas Pacific Land (TPL)
(Delayed Data from NYSE)
$818.85 USD
+11.29 (1.40%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $819.94 +1.09 (0.13%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
TPL 818.85 +11.29(1.40%)
Will TPL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TPL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TPL
5 Alternative Energy Stocks to Buy Amid Solid Industry Rally
Is SM Energy (SM) Stock Outpacing Its Oils-Energy Peers This Year?
TPL: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Alternative Energy Stocks to Buy Backed by EV Market Boom
Best Momentum Stock to Buy for June 27th
Best Momentum Stock to Buy for June 25th
Other News for TPL
Zelikovic Investments Letter (Updated Q2 - 2024)
Texas Pacific Land Corporation Sets Dates for Second Quarter 2024 Earnings Release and Conference Call
Betting The Farm - These 6 Dividend Stocks Dominate Our Family's Portfolios
Morning Brew: CrowdStrike Joins S&P 500, Micron's Target Raised, Alimera Sciences Acquired
Oppenheimer spotlights top buy/sell ideas for mid and small cap names